# A Clinical Study of ONO-1110 in Patients With Fibromyalgia

> **NCT06752590** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 160 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** ONO-1110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06752590
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752590, "A Clinical Study of ONO-1110 in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06752590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*